flurbiprofen has been researched along with urb 597 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cipriano, M; Fowler, CJ; Kaczor, AA; Koshevoy, IO; Laitinen, JT; Laitinen, T; Leppänen, J; Navia-Paldanius, D; Nevalainen, T; Parkkari, T; Patel, JZ; Poso, A; Saario, SM; Savinainen, JR | 1 |
Albani, C; Armirotti, A; Bertozzi, SM; Habrant, D; Migliore, M; Piomelli, D; Sasso, O; Scarpelli, R | 1 |
Lam, FF; Luk, PW; Ng, ES | 1 |
Congiu, C; Deplano, A; Fowler, CJ; Fredriksson Sundbom, M; Gouveia-Figueira, S; Hashemian, S; Karlsson, J; Onnis, V; Svensson, M | 1 |
4 other study(ies) available for flurbiprofen and urb 597
Article | Year |
---|---|
Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors.
Topics: Amidohydrolases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Oxadiazoles; Recombinant Proteins; Structure-Activity Relationship | 2013 |
Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Design; Humans; Mice; Stereoisomerism; Structure-Activity Relationship | 2016 |
Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Topics: Amidohydrolases; Analysis of Variance; Animals; Arachidonic Acids; Benzamides; Blood Vessels; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Capsaicin; Carbamates; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endocannabinoids; Flurbiprofen; Hindlimb; Indoles; Joints; Morpholines; Polyunsaturated Alkamides; Pyrazoles; Rats; Regional Blood Flow; TRPV Cation Channels; Vasodilation | 2007 |
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Topics: Amides; Amidohydrolases; Animals; Arachidonic Acid; Arachidonic Acids; Benzamides; Brain; Carbamates; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Endocannabinoids; Flurbiprofen; Humans; Hydrolysis; Interferon-gamma; Ionomycin; Isoenzymes; Lipid Metabolism; Lipopolysaccharides; Male; Mice; Polyunsaturated Alkamides; Prostaglandins; RAW 264.7 Cells; Stereoisomerism | 2015 |